India Takes Action Against 90% of Inspected High Risk Pharmaceutical Facilities: Regulator The Indian government has announced enforcement action against nearly 90% of high risk pharmaceutical facilities inspected during a nationwide quality drive.
This move has been hailed as a significant step towards improving drug safety and quality in the country.
However, closer examination reveals that this crackdown may be more a response to external pressure than a genuine attempt to address systemic issues within India's pharmaceutical industry.